Sikarin Past Earnings Performance
Past criteria checks 2/6
Sikarin has been growing earnings at an average annual rate of 32.8%, while the Healthcare industry saw earnings growing at 20.9% annually. Revenues have been growing at an average rate of 13.2% per year. Sikarin's return on equity is 12%, and it has net margins of 15.3%.
Key information
32.8%
Earnings growth rate
32.2%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | 13.2% |
| Return on equity | 12.0% |
| Net Margin | 15.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Sikarin makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 5,839 | 891 | 870 | 0 |
| 30 Sep 23 | 5,497 | 843 | 779 | 0 |
| 30 Jun 23 | 5,359 | 898 | 742 | 0 |
| 31 Mar 23 | 5,294 | 843 | 759 | 0 |
| 31 Dec 22 | 5,698 | 1,012 | 746 | 0 |
| 30 Sep 22 | 7,027 | 1,676 | 994 | 0 |
| 30 Jun 22 | 7,273 | 1,708 | 1,057 | 0 |
| 31 Mar 22 | 7,123 | 1,682 | 1,017 | 0 |
| 31 Dec 21 | 6,368 | 1,395 | 1,011 | 0 |
| 30 Sep 21 | 4,894 | 671 | 814 | 0 |
| 30 Jun 21 | 4,254 | 434 | 730 | 0 |
| 31 Mar 21 | 3,923 | 372 | 702 | 0 |
| 31 Dec 20 | 3,900 | 350 | 694 | 0 |
| 30 Sep 20 | 3,826 | 299 | 693 | 0 |
| 30 Jun 20 | 3,824 | 300 | 706 | 0 |
| 31 Mar 20 | 3,828 | 243 | 723 | 0 |
| 31 Dec 19 | 3,744 | 243 | 710 | 0 |
| 30 Sep 19 | 3,690 | 262 | 691 | 0 |
| 30 Jun 19 | 3,613 | 259 | 679 | 0 |
| 31 Mar 19 | 3,550 | 270 | 650 | 0 |
| 31 Dec 18 | 3,474 | 242 | 639 | 0 |
| 30 Sep 18 | 3,384 | 234 | 618 | 0 |
| 30 Jun 18 | 3,308 | 207 | 605 | 0 |
| 31 Mar 18 | 3,244 | 186 | 597 | 0 |
| 31 Dec 17 | 3,180 | 163 | 600 | 0 |
| 30 Sep 17 | 3,065 | 209 | 577 | 0 |
| 30 Jun 17 | 2,855 | 184 | 549 | 0 |
| 31 Mar 17 | 2,654 | 181 | 507 | 0 |
| 31 Dec 16 | 2,461 | 190 | 463 | 0 |
| 30 Sep 16 | 2,307 | 116 | 450 | 0 |
| 30 Jun 16 | 2,180 | 107 | 429 | 0 |
| 31 Mar 16 | 2,114 | 121 | 425 | 0 |
| 31 Dec 15 | 2,025 | 116 | 415 | 0 |
| 30 Sep 15 | 1,951 | 140 | 380 | 0 |
| 30 Jun 15 | 1,909 | 151 | 355 | 0 |
| 31 Mar 15 | 1,872 | 142 | 350 | 0 |
| 31 Dec 14 | 1,879 | 158 | 349 | 0 |
| 30 Sep 14 | 1,856 | 148 | 364 | 0 |
| 30 Jun 14 | 1,831 | 148 | 374 | 0 |
| 31 Mar 14 | 1,786 | 158 | 359 | 0 |
| 31 Dec 13 | 1,706 | 149 | 341 | 0 |
| 30 Sep 13 | 1,663 | 136 | 336 | 0 |
| 30 Jun 13 | 1,622 | 126 | 329 | 0 |
Quality Earnings: SKR has high quality earnings.
Growing Profit Margin: SKR's current net profit margins (15.3%) are lower than last year (17.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SKR's earnings have grown significantly by 32.8% per year over the past 5 years.
Accelerating Growth: SKR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SKR had negative earnings growth (-11.9%) over the past year, making it difficult to compare to the Healthcare industry average (-29.6%).
Return on Equity
High ROE: SKR's Return on Equity (12%) is considered low.